All In Biotech

Drug Trial Radar · NCT07412704

A Study of BMS-986528 in Participants With Refractory Rheumatoid Arthritis

A Phase 1/2a, Open-label, First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of BMS-986528 in Participants With Refractory Rheumatoid Arthritis

Last checked: Nov 19, 2026Latest source record: Nov 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

84

Planned (sponsor's estimate)

Start

Oct 6, 2026

Primary completion

Oct 30, 2029

Study completion Sep 2, 2030

Sponsor

Lead sponsor
Bristol-Myers SquibbBristol Myers Squibb (BMY)
Sponsor type
Industry
First posted
Feb 17, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1 / Phase 2
Allocation
Non randomized
Model
Sequential
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and the preliminary evidence of disease-modifying effect of BMS-986528 in participants with refractory, difficult-to-treat rheumatoid arthritis (RA).

Conditions

  • Arthritis, Rheumatoid

Interventions

  • BMS-986528Drug

    Specified dose on specified days

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of participants with treatment-emergent adverse events (TEAEs)Time frame: Up to Week 54
  2. Number of participants with Serious Adverse Events (SAEs)Time frame: Up to Week 54

Locations

39 sites in 11 countries. Site status is shown where the registry gives one.

  • UCSD - Altman Clinical and Translational Research Institute (ACTRI)

    La Jolla, California · Recruiting

  • Local Institution - 0070

    Loma Linda, California · Withdrawn

  • Local Institution - 0069

    Palo Alto, California · Not yet recruiting

  • Local Institution - 0050

    Aurora, Colorado · Not yet recruiting

  • Colorado Blood Cancer Institute

    Denver, Colorado · Recruiting

  • Local Institution - 0055

    South Miami, Florida · Not yet recruiting

  • Local Institution - 0081

    New York, New York · Not yet recruiting

  • Local Institution - 0079

    New York, New York · Not yet recruiting

  • Local Institution - 0066

    Portland, Oregon · Not yet recruiting

  • Local Institution - 0071

    Philadelphia, Pennsylvania · Withdrawn

  • Local Institution - 0051

    DeSoto, Texas · Withdrawn

  • Local Institution - 0049

    Leuven, Belgium · Not yet recruiting

  • Local Institution - 0048

    Merksem, Flanders, Belgium · Not yet recruiting

  • Local Institution - 0083

    Aparecida de Goiânia, Goiás, Brazil · Not yet recruiting

  • Local Institution - 0033

    Porto Alegre, Rio Grande do Sul, Brazil · Not yet recruiting

  • Local Institution - 0082

    Valinhos, São Paulo, Brazil · Not yet recruiting

  • Local Institution - 0006

    Beijing, Beijing Municipality, China · Not yet recruiting

  • Local Institution - 0080

    Guangzhou, Guangdong, China · Not yet recruiting

  • Local Institution - 0010

    Zhengzhou, Henan, China · Not yet recruiting

  • Local Institution - 0007

    Nanchang, Jiangxi, China · Not yet recruiting

  • Local Institution - 0020

    Shanghai, Shanghai Municipality, China · Not yet recruiting

  • Local Institution - 0001

    Shanghai, Shanghai Municipality, China · Not yet recruiting

  • Charité Research Organisation

    Berlin, Germany · Recruiting

  • Local Institution - 0021

    Cologne, Germany · Not yet recruiting

  • Rheumazentrum Ruhrgebiet

    Herne, Germany · Recruiting

  • St. Josef-Stift Sendenhorst

    Sendenhorst, Germany · Recruiting

  • Local Institution - 0040

    München, Bavaria, Germany · Not yet recruiting

  • Fondazione Policlinico Gemelli IRCCS

    Roma, Italy · Recruiting

  • Istituto Clinico Humanitas

    Rozzano, Milano, Italy · Recruiting

  • Local Institution - 0053

    México, Mexico · Not yet recruiting

  • Local Institution - 0023

    Józefów, Masovian Voivodeship, Poland · Not yet recruiting

  • Hospital Universitario Reina Sofia

    Córdoba, Spain · Recruiting

  • CHUAC-Complejo Hospitalario Universitario A Coruña

    A Coruña, A Coruña [La Coruña], Spain · Recruiting

  • Universitaetsspital Bern - Inselspital

    Bern, Switzerland · Recruiting

  • Hôpitaux Universitaire de Genève

    Geneva, Switzerland · Recruiting

  • Local Institution - 0064

    Kyiv, Ukraine · Not yet recruiting

  • Local Institution - 0061

    Ternopil, Ukraine · Not yet recruiting

  • Local Institution - 0060

    Ivano-Frankivsk, Ivano-Frankivsk Oblast, Ukraine · Not yet recruiting

  • Local Institution - 0063

    Poltava, Poltava Oblast, Ukraine · Not yet recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.